Save the date: Alligator Bioscience to host Capital Markets Day in Stockholm on 29 May 2018
Lund, Sweden, 18 April 2018 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, will host a Capital Markets Day in Stockholm on Tuesday 29 May 2018 for investors, analysts and media. The event will provide a detailed update on Alligator’s project pipeline, including a discussion on the future development of immuno-oncology antibodies. The program will start at 2:00 pm CEST, with registration from 1:00 pm CEST and will end with networking at 5:00 pm CEST. The event will take place at GT30,